Biotech Values

[iandy]

CTRV - anyone follow this one?
FV - 100 in Phase 3

FV-100 CLINICAL HIGHLIGHTS

Phase 1 and 2 trials of FV-100 were successfully completed. ContraVir is initiating a pivotal Phase 3 trial in patients with shingles to further explore FV-100’s potential ability to reduce shingles pain.
Demonstrated Safety and Efficacy
>350 patients treated with FV-100
Clinically meaningful reduction in PHN occurrence versus valacyclovir
Meaningful reduction in time to resolution of clinically significant pain
8-10% fewer patients required narcotics for pain control
Safety similar to other antivirals
Reduction in PHN at 90 days vs. Valacyclovir

In Phase 2 trials, FV-100 demonstrated a clinically meaningful 37% reduction in the incidence of PHN versus valacyclovir (Valtrex®).

http://contravir.com/fv-100/